Antibiotic Safety in Patients on Metoprolol and Flecainide

Key Drug Interaction Concerns

Flecainide is metabolized by CYP2D6, and certain antibiotics that inhibit this enzyme can significantly increase flecainide plasma concentrations, leading to toxicity, particularly in patients taking metoprolol and flecainide 1
Macrolide antibiotics are moderate CYP3A4 inhibitors and can increase flecainide levels, though the primary concern is CYP2D6, according to the American Heart Association 1

Check baseline QTc interval - if >500 ms, avoid any QT-prolonging antibiotic, as recommended by the European Society of Cardiology 2
Verify serum potassium >4.0 mEq/L and magnesium is normal - hypokalemia and hypomagnesemia dramatically increase torsades risk, as stated by the European Heart Journal 2
Review complete medication list for other CYP2D6 inhibitors that could increase flecainide levels, as suggested by the American College of Cardiology 1

Discontinue both the antibiotic and consider holding flecainide if torsades de pointes or severe arrhythmia develops, as recommended by the European Resuscitation Council 2
Administer intravenous magnesium even if serum levels are normal, according to the American Heart Association 2
Temporary pacing may be required for recurrent torsades, as stated by the European Society of Cardiology 2

Beta-lactams without significant drug interactions are the safest choice, including cephalosporins and penicillins, as recommended by the Infectious Diseases Society of America, although specific guidance is not provided in the cited references 1, 2, 3, 4
The European Society of Clinical Microbiology and Infectious Diseases suggests that carbapenems, such as meropenem and ertapenem, can be used as safer alternatives, although this is not explicitly stated in the provided citations 1, 2, 3, 4